supp.fit

Epigallocatechin Gallate and Green Tea Extract: study protocols

16 study groups took Epigallocatechin Gallate together with Green Tea Extract. These are the doses the studies gave. They are not a recommendation.

Epigallocatechin Gallate: what the research found →

Dose per serving from research: Epigallocatechin Gallate

16 study groups in 12 studies say how much Epigallocatechin Gallate participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 50% of 16 study groups.

Daily doseStudy groups
100 mg to 250 mg
2
250 mg to 500 mg
6
500 mg to 1 g
8

Dose per serving from research: Green Tea Extract

11 study groups in 8 studies say how much Green Tea Extract participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 64% of 11 study groups.

Daily doseStudy groups
250 mg to 500 mg
2
500 mg to 1 g
2
1 g to 2.5 g
7

Commonly used together

2 of 16 study groups took Epigallocatechin Gallate and Green Tea Extract with something else, but nothing that 3 or more different studies gave.

16 study groups

Study
Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial
2016 · decaffeinated green tea extract group · Women aged 25–45 years with moderate-to-severe post-adolescent acne
856 mg1.5 g4 weeks—
A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)
2025 · MLI+EGCG, participants weighing 50 kg or less · Adults aged 60–80 with subjective cognitive decline who carried APOE-ε4 and had normal-range cognitive performance
300 mg677 mg1 year—
A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)
2025 · MLI+EGCG, participants weighing more than 50 kg · Adults aged 60–80 with subjective cognitive decline who carried APOE-ε4 and had normal-range cognitive performance
500 mg1.13 g1 year—
A Randomized, Placebo-Controlled Study on the Safety and Efficacy of Daily Ingestion of Green Tea (Camellia sinensis L.) cv. "Yabukita" and "Sunrouge" on Eyestrain and Blood Pressure in Healthy Adults
2018 · Sunrouge group · Japanese adults aged 21–55 years with slightly elevated blood pressure
324 mg—12 weeks39
A Randomized, Placebo-Controlled Study on the Safety and Efficacy of Daily Ingestion of Green Tea (Camellia sinensis L.) cv. "Yabukita" and "Sunrouge" on Eyestrain and Blood Pressure in Healthy Adults
2018 · Yabukita group · Japanese adults aged 21–55 years with slightly elevated blood pressure
322 mg—12 weeks38
Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients
2012 · GTE group · Adults aged 30–60 with obesity (BMI ≥30 kg/m²), 23 men and 23 women across the study
208 mg379 mg90 days23
Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene
2025 · EGCG · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids
720 mg1.6 g30 days12
Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene
2025 · EGCG + letrozole · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids
720 mg1.6 g30 days10
Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene
2025 · EGCG + clomiphene · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids
720 mg1.6 g30 days8
The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial
2015 · GTE · Postmenopausal women aged 50–70 years with high mammographic density and no history of cancer or proliferative breast disease
843 mg1.32 g1 year538
Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial
2016 · GTE · Healthy postmenopausal women
843 mg—1 year538
Green tea extract supplementation does not modify plasma concentration of F(2)-isoprostanes in women who are postmenopause: Findings from a randomized controlled trial
2023 · GTE intervention · Postmenopausal women aged 50–70 years, generally healthy and at increased breast-cancer risk due to high breast tissue density
843 mg—1 year131
Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women
2017 · GTE · Postmenopausal women aged 50–70 years who were overweight or obese and had dense breast tissue
843 mg1.32 g1 year30
Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers
2021 · GTE phase · Healthy Japanese adults aged 21–29 years; 7 men and 5 women enrolled
300 mg325 mg1 day10
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome
2011 · green tea extracts · Adults with obesity and metabolic syndrome; age and sex not further specified
460 mg1 g8 weeks—
Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers
2018 · Green tea extract (GTE) · Healthy volunteers; age and sex not reported
150 mg—1 day—